This inventor holds 4 USPTO granted patents and 1 published patent application. Top assignees: Yeda Research and Develpment & Co. Ltd, The United States of America, as Represented by the Secretary, Department of Health and Human Services, Other. Active years: 1999-2012.
Location History:
- Doar Korazin, IL (1999)
- D.N. Hevel Korazim, IL (2010)
- Hevel KoraZim, IL (2012)
Company Filing History:
3 out of 1,168 
1 out of 3,690 
1 out of 834,411 Years Active: 1999-2012
Title: Gideon Gross: Innovator in Chimeric Receptor Technology
Introduction
Gideon Gross is a notable inventor based in Hevel KoraZim, IL. He has made significant contributions to the field of biotechnology, particularly in the development of chimeric receptor genes. With a total of 4 patents to his name, Gross has established himself as a key figure in innovative therapeutic methods.
Latest Patents
One of Gross's latest patents focuses on chimeric receptor genes and the cells transformed therewith. These chimeric receptor genes are designed to endow lymphocytes with antibody-type specificity. The invention includes a first gene segment that encodes a single-chain Fv domain of a specific antibody and a second gene segment that encodes all or part of the transmembrane and cytoplasmic domains, and optionally the extracellular domain, of an immune cell-triggering molecule. When the chimeric receptor gene is transfected into immune cells, it expresses the antibody-recognition site and the immune cell-triggering moiety as a continuous chain. The transformed lymphocytes resulting from this process are useful in various therapeutic treatment methods.
Career Highlights
Gideon Gross has worked with prominent organizations, including Yeda Research and Development Company Ltd and the United States of America, as represented by the Secretary, Department of Health and Human Services. His work in these institutions has contributed to advancements in medical research and therapeutic applications.
Collaborations
Throughout his career, Gross has collaborated with esteemed colleagues such as Zelig Eshhar and Tova Waks. These partnerships have further enhanced the impact of his innovations in the field.
Conclusion
Gideon Gross is a pioneering inventor whose work in chimeric receptor technology has the potential to revolutionize therapeutic treatments. His contributions continue to influence the biotechnology landscape, showcasing the importance of innovation in healthcare.